QHSLab, Inc. Files 8-K

Ticker: USAQ · Form: 8-K · Filed: Dec 3, 2025 · CIK: 856984

Sentiment: neutral

Topics: 8-K, regulatory-disclosure, financial-exhibits

TL;DR

QHSLab (QHS) filed an 8-K on 12/3/25 - check for Reg FD and financials.

AI Summary

QHSLab, Inc. filed an 8-K on December 3, 2025, reporting information under Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as USA EQUITIES CORP. and AMERICAN BIOGENETIC SCIENCES INC, is incorporated in Nevada and operates in the Surgical & Medical Instruments & Apparatus industry.

Why It Matters

This filing indicates QHSLab, Inc. is making a regulatory disclosure and providing financial statements, which could signal significant business events or updates to investors.

Risk Assessment

Risk Level: low — The filing is a standard 8-K for regulatory disclosure and financial exhibits, not indicating immediate financial distress or significant negative events.

Key Numbers

Key Players & Entities

FAQ

What specific information is being disclosed under Regulation FD?

The filing indicates a Regulation FD Disclosure, but the specific details of the disclosure are not provided in this header information.

What types of financial statements and exhibits are included?

The filing lists 'Financial Statements and Exhibits' as an item, but the specific contents are not detailed in this summary.

When was QHSLab, Inc. previously known as USA EQUITIES CORP.?

The date of name change from USA EQUITIES CORP. to QHSLab, Inc. was November 19, 2015.

What is the company's primary industry classification?

QHSLab, Inc. is classified under 'SURGICAL & MEDICAL INSTRUMENTS & APPARATUS' with SIC code 3841.

Where is QHSLab, Inc. headquartered?

The company's business and mail address is 901 Northpoint Parkway Suite 302, West Palm Beach, FL 33407.

Filing Stats: 749 words · 3 min read · ~2 pages · Grade level 10.8 · Accepted 2025-12-03 08:30:49

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this current report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: December 3, 2025 QHSLab, Inc. /s/ Troy Grogan Name: Troy Grogan Title: CEO and Chairman

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing